Physician, Assistant Professor
Neuromuscular Medicine, Neurology
Department: Neurology
I specialize in diagnosing and treating patients with neuromuscular disorders, conditions affecting the peripheral nerves and muscles. I commonly see patients for issues including myasthenia gravis, Guillain–Barré syndrome, and Charcot–Marie–Tooth disease (CMT).
I believe the most important thing a doctor can do is spend time listening to their patients. I enjoy getting to know each patient so I can customize a treatment plan that best aligns with their needs and focuses on what matters most to them.
I am involved in clinical and translational research focused on autoimmune neuromuscular disorders. I have a particular interest in neuromuscular disorders caused by the immune system, which are often challenging to diagnose and treat. My goal is to develop more advanced treatment options that lead to better outcomes for patients.
Please note: Not all physicians schedule patients at each listed location.
The overall patient satisfaction rating is an average of all patient responses to the six doctor communication related questions shown below from the Clinician and Group Consumer Assessment of Healthcare Providers and Systems survey. For additional information about the patient satisfaction survey, please visit our Patient Satisfaction Survey page.
The comments are submitted by patients and reflect their view and opinions. The comments are not endorsed by and do not necessarily reflect the views of Ohio State Wexner Medical Center.
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.
As of 11/3/2025, Alexander Morrison has reported no relationships with companies or entities.
